Adaptimmune Therapeutics (ADAP) Earnings
|
Expand Research on ADAP
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | +90.0% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | 0.0% | Normal Earnings Time | N/A |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
11/5/25  |
Q325 | N/A | -$0.04 | N/A | N/A | $4.85M | N/A | N/A | N/A | ||
| 8/13/25 |
Q225 | -$0.02 | -$0.05 | +$0.03 | $13.67M | $11.19M | N/A |  | | Details | |
| 8/8/25 |
Q225 | N/A | -$0.05 | N/A | N/A | $11.19M | N/A | N/A | N/A | ||
| 8/6/25 |
Q225 | N/A | -$0.05 | N/A | N/A | $11.19M | N/A | N/A | N/A | ||
| 5/13/25 | Q125 | -$0.03 | -$0.12 | +$0.09 | $7.29M | $7.55M | N/A | | | Details | |
| 3/20/25 |
Q424 | N/A | -$0.03 | N/A | N/A | $7.75M | N/A | N/A | N/A | ||
| 3/10/25 |
Q424 | N/A | -$0.03 | N/A | N/A | $7.75M | N/A | N/A | N/A | ||
| 3/7/25 |
Q424 | N/A | -$0.03 | N/A | N/A | $7.75M | N/A | N/A | N/A |
